Clinical Trials Logo

Clinical Trial Summary

This study is designed to determine the ED90 for an infusion of phenylephrine to prevent spinal induced low blood pressure in parturients presenting for an elective cesarean delivery. The up-down methodology (UDM) is commonly used study method to determine the dose of a drug that causes the desired effect in over 90% of the subjects to whom it given. For example: the investigators want to know what is the best dose of phenylephrine (from a range of commonly used doses) to prevent a drop in blood pressure during cesarean delivery ninety times out of one hundred when it is given at that dose. The ED90 is the effective dose at which 90% of subjects will have a "positive" response to a phenylephrine infusion, i.e. no drop in blood pressure. The investigators hypothesize that the ED90 will be between 40 - 60 mcg/min.

The primary outcome measure is the ED90 for phenylephrine infusions that prevents a drop in blood pressure in women undergoing cesarean delivery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Hypotension
  • Spinal Induced Hypotension in Cesarean Delivery

NCT number NCT00796328
Study type Interventional
Source IWK Health Centre
Contact
Status Terminated
Phase Phase 4
Start date November 2008
Completion date July 2009